news
Merger between Daiichi Sankyo subsidiary Ranbaxy and Sun Pharma completed
25 March 2015 | By Victoria White
Daiichi Sankyo have announced that the Sun Pharma and Ranbaxy merger process has been completed...
List view / Grid view
Ranbaxy Laboratories Ltd
news
Announcement regarding merger between Sun Pharma and Daiichi Sankyo’s subsidiary Ranbaxy and resulting change in subsidiary
11 April 2014 | By Daiichi Sankyo
As announced in a release dated April 7, 2014, pursuant to a merger transaction, whereby Daiichi Sankyo Company, Limited has agreed with Sun Pharmaceutical Industries Ltd...
news
Daiichi Sankyo agrees to vote its shares in Ranbaxy in favor of Sun Pharma’s Acquisition
7 April 2014 | By Daiichi Sankyo
Pursuant to the merger transaction announced between Ranbaxy Laboratories Limited and Sun Pharmaceutical Industries Ltd. announces that it has agreed to vote its shares in Ranbaxy in favor of Sun Pharma’s acquisition of 100%...
news
Subpoena for Ranbaxy’s Toansa Plant
7 April 2014 | By Daiichi Sankyo
Attached is the statement of Ranbaxy Laboratories, a subsidiary of Daiichi Sankyo Company, Limited, which was issued on April 7th, 2014...
news
Ranbaxy suspends shipments of active pharmaceutical ingredients (APIs) produced at Indian plants
25 February 2014 | By Daiichi Sankyo Company
Daiichi Sankyo has announced that its consolidated subsidiary, Ranbaxy Laboratories, will temporarily suspended shipments of active pharmaceutical ingredients (APIs) produced at its Toansa and Dewas plants in India.
news
Update on Regarding the Import Alert on Ranbaxy’s Toansa Plant
24 January 2014 | By Daiichi Sankyo Company
Ranbaxy Laboratories Limited announced that the US FDA notified the company that it is prohibited from manufacturing and distributing active pharmaceutical ingredients from its facility in Toansa, India, for FDA-regulated drug products...
news
Regarding the import alert on Ranbaxy’s Toansa Plant
24 January 2014 | By Daiichi Sankyo
Daiichi Sankyo Company Ltd. announced that the US Food and Drug Administration has issued an import alert on January 23 on Active Pharmaceutical Ingredients...
news
Statement regarding FDA inspection of Ranbaxy’s Toansa plant
14 January 2014 | By Daiichi Sankyo Co., Ltd
Ranbaxy received the form 483 with certain observations as a result of the recent US FDA inspection at its API plant at Toansa, Punjab, India...
news
FDA imposes import ban on Ranbaxy’s Mohali plant
24 September 2013 | By Daiichi Sankyo Company, Limited
Ranbaxy Laboratories has received communication from the FDA about an Import Alert imposed on its Mohali, India, plant following an inspection in late 2012...
news
Ranbaxy announces conclusion of previously disclosed investigation by U.S Department of Justice
13 May 2013 | By DAIICHI SANKYO COMPANY, LIMITED
"Today’s announcement marks the resolution of this past issue..."
news
Sun shines on Indian generics manufacturers
3 April 2013 | By GlobalData
India is becoming a key market for generic medicines...
news
Daiichi Sankyo and Ranbaxy to leverage synergies in Thailand
16 January 2013 | By Daiichi Sankyo
Daiichi Sankyo and Ranbaxy announced their intention to integrate their business operations in Thailand...
news
Gilead Sciences announces new collaboration with Indian partners
2 August 2012 | By Gilead Sciences, Inc.
Gilead Sciences, Inc., together with Mylan Laboratories, Ranbaxy Laboratories Limited and Strides Arcolab, have entered into agreements...
news
Ranbaxy crosses $2bn in global sales
28 February 2012 | By Daiichi Sankyo Co., Ltd
The Board of Directors of Ranbaxy Laboratories Limited, took on record the audited results for the Quarter and Year ended December 31, 2011...
news
Teva announces agreement with Ranbaxy regarding Generic Lipitor®
30 November 2011 | By Teva
A portion of the profits from Ranbaxy’s sales of Atorvastatin Calcium Tablets during Ranbaxy’s 180-day first-to-file exclusivity period, will be paid to Teva...
